Literature DB >> 4115429

Protection of nonimmune volunteers against rubella by intravenous administration of normal human gamma globulin.

R Martin du Pan, B Koechli, A Douath.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4115429     DOI： 10.1093/infdis/126.3.341

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

1.  Comparison of multiple vaccine vectors in a single heterologous prime-boost trial.

Authors:  Brice Barefoot; Natalie J Thornburg; Daniel H Barouch; Jae-Sung Yu; Christopher Sample; Robert E Johnston; Hua Xin Liao; Thomas B Kepler; Barton F Haynes; Elizabeth Ramsburg
Journal:  Vaccine       Date:  2008-09-20       Impact factor: 3.641

2.  Rubella antibodies in Australian immunoglobulin products.

Authors:  Megan K Young; Joseph Bertolini; Pushpa Kotharu; Darryl Maher; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

3.  Trial of high-titre human rubella immunoglobulin.

Authors:  G E Urquhart; R J Crawford; J Wallace
Journal:  Br Med J       Date:  1978-11-11

Review 4.  Post-exposure passive immunisation for preventing rubella and congenital rubella syndrome.

Authors:  Megan K Young; Allan W Cripps; Graeme R Nimmo; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2015-09-09

5.  The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease.

Authors:  Amelia K Pinto; Mariah Hassert; Xiaobing Han; Douglas Barker; Trevor Carnelley; Emilie Branche; Tara L Steffen; E Taylor Stone; Elizabeth Geerling; Karla M Viramontes; Cory Nykiforuk; Derek Toth; Sujan Shresta; Shantha Kodihalli; James D Brien
Journal:  Front Immunol       Date:  2021-09-06       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.